Symbol not found

NASDAQ:CRDF   00:00AM GMT
0.00
0.00 (0.00%)
Earnings Announcements

Cardiff Oncology Inc - QTRLY Loss Per Share $0.24

Published: 08/04/2022 21:45 GMT
Cardiff Oncology Inc (CRDF) - Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates.
Qtrly Loss per Share $0.24.
Q2 Earnings per Share View $-0.25 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.06 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0.07 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.